Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
Fixed Capital/Sales

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.950.640.600.400.40

What is the latest Fixed Capital/Sales ratio of GLAND PHARMA ?

The latest Fixed Capital/Sales ratio of GLAND PHARMA is 0.95 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.95
Mar20240.64
Mar20230.60
Mar20220.40
Mar20210.40

How is Fixed Capital/Sales of GLAND PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.95
48.44
Mar2024 0.64
6.67
Mar2023 0.6
50.00
Mar2022 0.4
0.00
Mar2021 0.4 -

Other Financial Ratios of GLAND PHARMA


Compare Fixed Capital/Sales ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹29,565.9 Cr -1.3% -6.4% 1.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,044.0 Cr 1.5% 6.5% -1.5% Stock Analytics
DIVIS LABORATORIES ₹172,877.0 Cr 0.8% 0.3% 6.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,042.0 Cr 1% 4.4% 18.1% Stock Analytics
CIPLA ₹123,060.0 Cr -0.4% -3.8% 1.4% Stock Analytics
DR REDDYS LABORATORIES ₹104,190.0 Cr 0.1% -2.8% 1.8% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.3%

-6.4%

1.6%

SENSEX

0.5%

1.7%

11%


You may also like the below Video Courses